1-4 of 4
Anastasia Martynova
Close
Sort by
Journal Articles

Impact of FLT3 Inhibitor-Based Therapies on Outcomes of Acute Myeloid Leukemia (AML) Patients Receiving Allogenic Stem Cell Transplantation: A Retrospective Study

Krithika Chennapan, Karam Ashouri, Anastasia Martynova, Samvel Nazaretyan, Amir Ali, Eric Tam, Abdullah Ladha, Karrune Woan, Preet M. Chaudhary, Imran Siddiqi, George Yaghmour
Journal: Blood
Blood (2022) 140 (Supplement 1): 4823–4824.
https://doi.org/10.1182/blood-2022-163658
Published: 2022
Journal Articles

Updated Outcomes during the Pandemic: Relationship between CD34and CD3 Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation Using Post Transplant Cytoxan: A Single Center Experience

Anastasia Martynova, Krithika Chennapan, Jack Rodman, Mindy Hsiao, Abdullah Ladha, Eric Tam, Karrune Woan, Preet M. Chaudhary, George Yaghmour
Journal: Blood
Blood (2021) 138 (Supplement 1): 1773.
https://doi.org/10.1182/blood-2021-152625
Published: 2021
Journal Articles

The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19

Lantarima Bhoopat, MD, Anastasia Martynova, MD, April Choi, MD, Pattharawin Pattharanitima, MD, Semi Han, MD, Senxi Du, Ibrahim Syed, Catherine Chan, PharmD, Caitlin O'Neill, MD, Esther Oh, PharmD, Casey L. O'Connell, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-141732
Published: 2020
Journal Articles

Investigating the Relationship between CD34 + and CD3 + Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation: A Single Center Experience

Mindy Hsiao, MD, Anastasia Martynova, MD, George Yaghmour, MD, Chris Foss, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2051.
https://doi.org/10.1182/blood-2019-129647
Published: 2019